When we compared the YM155 sensitivity between cancer cell lines with high and low survivin expression, we found statistically significant differences across all cell lines in the GDSC and CTRP datasets but not across the neuroblastoma cell lines (Figure 3). This evidence concerns the gene BIRC5 and neuroblastoma.